Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
暂无分享,去创建一个
H. Nishiyama | K. Kuroiwa | O. Ogawa | A. Yokomizo | J. Inokuchi | S. Naito | C. Ohyama | H. Fujimoto | N. Masumori | T. Kojima | H. Matsuyama | Y. Kakehi | T. Ichikawa | J. Mizusawa | J. Eba | M. Eto | M. Gotoh | M. Sugimoto | Toshiki Tanigawa
[1] Do Kyung Kim,et al. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis. , 2019, Critical reviews in oncology/hematology.
[2] Myung Ha Kim,et al. Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma. , 2018, The Cochrane database of systematic reviews.
[3] Anthony Patterson,et al. NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.
[4] K. Kuroiwa,et al. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A , 2017, World Journal of Urology.
[5] Y. Kaiho,et al. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma , 2016, International journal of urology : official journal of the Japanese Urological Association.
[6] M. Babjuk,et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. , 2015, European urology.
[7] Wun-Jae Kim,et al. Effects of Previous or Synchronous Non-Muscle Invasive Bladder Cancer on Clinical Results after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multi-Institutional Study. , 2015, Urology journal.
[8] S. Shariat,et al. Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study , 2015, World Journal of Urology.
[9] O. Cussenot,et al. A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma. , 2015, European urology.
[10] F. Montorsi,et al. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. , 2014, European urology.
[11] C. Tulić,et al. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma. , 2013, Urologic oncology.
[12] Choung-Soo Kim,et al. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma. , 2013, Urologic oncology.
[13] M. Peyromaure,et al. Bladder recurrence after radical nephroureterectomy: Predictors and impact on oncological outcomes , 2013, International journal of urology : official journal of the Japanese Urological Association.
[14] Takuhiro Yamaguchi,et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] David A. Green,et al. Urothelial carcinoma of the bladder and the upper tract: disparate twins. , 2013, The Journal of urology.
[16] O. Cussenot,et al. Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study , 2013, World Journal of Urology.
[17] K. Bensalah,et al. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy. , 2012, Urologic oncology.
[18] T. O'brien,et al. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). , 2011, European urology.
[19] C. Compton,et al. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.
[20] Y. Sugimura,et al. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma , 2008, International journal of urology : official journal of the Japanese Urological Association.
[21] Liang Cheng,et al. Molecular Evidence Supporting Field Effect in Urothelial Carcinogenesis , 2005, Clinical Cancer Research.
[22] M. Kattan,et al. Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma. , 2004, The Journal of urology.
[23] G. Cancel-Tassin,et al. Microsatellite instability in urothelial carcinoma of the upper urinary tract. , 2003, The Journal of urology.
[24] T. Habuchi,et al. Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors. , 2001, The Journal of urology.
[25] L. Ellison,et al. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. , 2000, The Journal of urology.
[26] M. Jinzaki,et al. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study. , 2014, Urologic oncology.
[27] S. Crouzet,et al. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma. , 2014, Urologic oncology.